HK1201468A1 - 包括脂質微膠囊遞送媒劑的局部調配物和其用途 - Google Patents
包括脂質微膠囊遞送媒劑的局部調配物和其用途Info
- Publication number
- HK1201468A1 HK1201468A1 HK15102075.7A HK15102075A HK1201468A1 HK 1201468 A1 HK1201468 A1 HK 1201468A1 HK 15102075 A HK15102075 A HK 15102075A HK 1201468 A1 HK1201468 A1 HK 1201468A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- delivery vehicles
- topical formulations
- formulations including
- including lipid
- microcapsule delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Psychology (AREA)
- Nutrition Science (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161502810P | 2011-06-29 | 2011-06-29 | |
PCT/US2012/045095 WO2013003803A1 (en) | 2011-06-29 | 2012-06-29 | Topical formulations including lipid microcapsule delivery vehicles and their uses |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1201468A1 true HK1201468A1 (zh) | 2015-09-04 |
Family
ID=47424580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15102075.7A HK1201468A1 (zh) | 2011-06-29 | 2015-03-02 | 包括脂質微膠囊遞送媒劑的局部調配物和其用途 |
Country Status (8)
Country | Link |
---|---|
US (1) | US11065206B2 (zh) |
EP (1) | EP2726071B1 (zh) |
JP (1) | JP6322575B2 (zh) |
CN (1) | CN104023717B (zh) |
AU (1) | AU2012275091B2 (zh) |
CA (1) | CA2877102C (zh) |
HK (1) | HK1201468A1 (zh) |
WO (1) | WO2013003803A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8470304B2 (en) | 2009-08-04 | 2013-06-25 | Avidas Pharmaceuticals Llc | Therapeutic vitamin D sun-protecting formulations and methods for their use |
US11975010B2 (en) * | 2021-01-13 | 2024-05-07 | The Daily Suncare, LLC | Compositions for facilitating topical administration of vitamin D while protecting against UV light |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4182330A (en) | 1977-07-25 | 1980-01-08 | Alza Corporation | Means for administering amphipathic medicament |
US4356167A (en) | 1978-01-27 | 1982-10-26 | Sandoz, Inc. | Liposome drug delivery systems |
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
EP0043327B1 (fr) | 1980-07-01 | 1984-01-18 | L'oreal | Procédé d'obtention de dispersions stables dans une phase aqueuse d'au moins une phase liquide non miscible à l'eau et dispersions correspondantes |
US4725442A (en) | 1983-06-17 | 1988-02-16 | Haynes Duncan H | Microdroplets of water-insoluble drugs and injectable formulations containing same |
US4744989A (en) | 1984-02-08 | 1988-05-17 | E. R. Squibb & Sons, Inc. | Method of preparing liposomes and products produced thereby |
US4610868A (en) * | 1984-03-20 | 1986-09-09 | The Liposome Company, Inc. | Lipid matrix carriers for use in drug delivery systems |
US4572915A (en) * | 1984-05-01 | 1986-02-25 | Bioglan Laboratories | Clear micellized solutions of fat soluble essential nutrients |
EP0357773B1 (en) * | 1987-02-27 | 1992-07-15 | Terumo Kabushiki Kaisha | Process for preparing liposomes |
US4911928A (en) | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
US4824675A (en) | 1987-07-13 | 1989-04-25 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
DE3919982A1 (de) | 1989-06-19 | 1990-12-20 | Liedtke Pharmed Gmbh | Orale lipidarzneiform |
CH677886A5 (zh) | 1989-06-26 | 1991-07-15 | Hans Georg Prof Dr Weder | |
FR2725369B1 (fr) * | 1994-10-07 | 1997-01-03 | Oreal | Composition cosmetique ou dermatologique constituee d'une emulsion huile dans eau a base de globules huileux pourvus d'un enrobage cristal liquide lamellaire |
US5629021A (en) | 1995-01-31 | 1997-05-13 | Novavax, Inc. | Micellar nanoparticles |
AU7364896A (en) * | 1995-10-10 | 1997-04-30 | Marilyn Strube | Treatment of pruritus with vitamin d and analogs thereof |
US5720948A (en) * | 1995-11-07 | 1998-02-24 | Helene Curtis Inc. | Non-ionic surfactant emulsion vehicles and their use for deposition of drug into and across skin |
EP0892638B1 (en) * | 1996-04-04 | 2002-11-13 | Cilag AG | Liposome-based topical vitamin d formulation |
DK0979654T3 (da) * | 1998-03-04 | 2006-01-02 | Teijin Ltd | Emulsionslotioner med aktivt vitamin D3 |
TR200101790T2 (tr) * | 1998-12-23 | 2001-10-22 | Idea Ag. | Yayılgan olmayan in vivo topik uygulamalar için geliştirilmiş formül |
JP4637991B2 (ja) * | 1999-07-27 | 2011-02-23 | 株式会社資生堂 | マイクロカプセル及びその製造方法 |
JP2002338458A (ja) * | 2001-03-09 | 2002-11-27 | Eau De Faveur:Kk | 皮膚外用剤 |
ATE429274T1 (de) * | 2001-07-31 | 2009-05-15 | Merck Patent Gmbh | Sonnenschutzzusammensetzung |
EP1684724A4 (en) * | 2003-11-19 | 2008-04-02 | Barnes Jewish Hospital | IMPROVED DRUG DELIVERY |
US7790190B2 (en) * | 2004-03-20 | 2010-09-07 | Yasoo Health, Inc. | Aqueous emulsions of lipophile solubilized with vitamin E TPGS and linoleic acid |
CA2581775A1 (en) * | 2004-09-27 | 2006-04-06 | Sigmoid Biotechnologies Limited | Dihydropyrimidine microcapsule - formulations |
US20080033027A1 (en) * | 2005-03-21 | 2008-02-07 | Vicus Therapeutics Spe 1, Llc | Drug combination pharmaceutical compositions and methods for using them |
JP2010516695A (ja) * | 2007-01-18 | 2010-05-20 | マーク エー. ピンスカイ | 抗酸化剤を皮膚内に送達するための材料および方法 |
JP4341983B2 (ja) * | 2007-12-07 | 2009-10-14 | 株式会社資生堂 | 皮膚外用剤 |
KR20170029019A (ko) * | 2008-07-18 | 2017-03-14 | 바이오모드 컨셉츠 인코포레이티드 | 활성 성분을 방출하는 제품 |
US20100080768A1 (en) * | 2008-09-26 | 2010-04-01 | Mcgraw Thomas L | Compositions and Methods for the Treatment of Inflammatory Dermatosis and Other Pathological Conditions of the Skin |
US8470304B2 (en) * | 2009-08-04 | 2013-06-25 | Avidas Pharmaceuticals Llc | Therapeutic vitamin D sun-protecting formulations and methods for their use |
WO2011049248A1 (ja) * | 2009-10-23 | 2011-04-28 | 東レ・ダウコーニング株式会社 | 新規な共変性オルガノポリシロキサン |
-
2012
- 2012-06-29 US US14/129,747 patent/US11065206B2/en active Active
- 2012-06-29 EP EP12804394.0A patent/EP2726071B1/en active Active
- 2012-06-29 CA CA2877102A patent/CA2877102C/en active Active
- 2012-06-29 AU AU2012275091A patent/AU2012275091B2/en active Active
- 2012-06-29 CN CN201280042074.0A patent/CN104023717B/zh active Active
- 2012-06-29 WO PCT/US2012/045095 patent/WO2013003803A1/en active Application Filing
- 2012-06-29 JP JP2014519195A patent/JP6322575B2/ja active Active
-
2015
- 2015-03-02 HK HK15102075.7A patent/HK1201468A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US11065206B2 (en) | 2021-07-20 |
JP2014522848A (ja) | 2014-09-08 |
EP2726071A1 (en) | 2014-05-07 |
CA2877102A1 (en) | 2013-01-03 |
CA2877102C (en) | 2020-06-30 |
JP6322575B2 (ja) | 2018-05-09 |
WO2013003803A1 (en) | 2013-01-03 |
EP2726071A4 (en) | 2015-04-15 |
AU2012275091A1 (en) | 2014-02-20 |
AU2012275091B2 (en) | 2017-08-03 |
EP2726071C0 (en) | 2023-10-11 |
CN104023717B (zh) | 2017-08-04 |
EP2726071B1 (en) | 2023-10-11 |
CN104023717A (zh) | 2014-09-03 |
US20140348910A1 (en) | 2014-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181855T1 (hr) | Lipidi za formulacije namijenjene unosu terapijskog sredstva | |
ZA201502352B (en) | Liposomal drug delivery system | |
ZA201504369B (en) | Tetracycline topical formulations, preparation and uses thereof | |
HK1199206A1 (zh) | 遞送的脂質納米顆粒組合物和方法 | |
IL229083A0 (en) | Stabilized skin formulations that include microcapsules | |
EP2701734A4 (en) | LIPOSOMAL FORMULATIONS | |
EP2804606A4 (en) | TOPICAL THERAPEUTIC FORMULATIONS | |
HK1218723A1 (zh) | 液體的局部藥用的納米乳液製劑 | |
EP2753179A4 (en) | TOPICAL FORMULATIONS OF ITRACONAZOLE AND USES THEREOF | |
SG10201606161UA (en) | Albumin Formulation and Use | |
EP2685993A4 (en) | PHARMACEUTICAL COMPOSITIONS AND TOPICAL USE THEREOF | |
IL235363A0 (en) | Means for releasing pesticides | |
HK1201468A1 (zh) | 包括脂質微膠囊遞送媒劑的局部調配物和其用途 | |
SG11201405743QA (en) | Liposomal delivery system | |
EP2908800B8 (en) | Composition and delivery vehicle for active agents and methods therefor | |
GB201210713D0 (en) | Improvements in and relating to attendant propelled vehicles | |
GB201018773D0 (en) | Topical pharmaceutical formulation | |
IL229356A0 (en) | Preparations for topical administration containing nitrous oxide gas | |
GB201204597D0 (en) | Topical pharmaceutical formulation | |
GB201110027D0 (en) | Topical formulation | |
GB201110030D0 (en) | Topical formulation | |
IL229936B (en) | Albumin formulation and use | |
AU2012901190A0 (en) | Liposome Compositions and Systems for Drug Delivery | |
AU2011900932A0 (en) | Pharmaceutical compositions and topical use thereof |